Ignite Creation Date:
2024-05-06 @ 2:55 AM
Last Modification Date:
2024-10-26 @ 11:25 AM
Study NCT ID:
NCT02151903
Status:
TERMINATED
Last Update Posted:
2020-11-27
First Post:
2014-05-23
Brief Title:
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL
Sponsor:
Alopexx Oncology LLC
Organization:
Alopexx Oncology LLC
Organization Data
Organization:
Alopexx Oncology LLC
Class:
INDUSTRY
Study ID:
AO-101-EXT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alopexx Oncology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None